FIELD: medicine.
SUBSTANCE: disclosed is application of 7-hydroxyepiandrosteron as active agent for protection from acute or chronic neuron damage caused by hypoxia, ischemia, stroke, brain trauma, Alzheimer's disease, Parkinson's disease, or spinal cord damage. 7-Hydroxyepiandrosteron increases number of pyramidal cell survivor after ischemia or hypoxia.
EFFECT: new agent with neuroprotective activity.
6 cl, 1 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROPROTECTIVE 7-BETA-HYDROXYSTEROIDS | 2001 |
|
RU2258511C2 |
| PREVENTIVE AND THERAPEUTIC HYDROXIDE APPLICATION | 2002 |
|
RU2329049C2 |
| PROSTAGLANDIN/CYCLOOXYGENASE PATHWAY MODULATION | 2007 |
|
RU2448712C2 |
| METHOD OF REDUCING DEMAGE TO NERVOUS CELLS | 2007 |
|
RU2464977C2 |
| METHOD FOR PREVENTING ISCHEMIC AND REPERFUSION INJURIES OF THE HIPPOCAMPUS NEURONS IN THE POSTRESUSCITATIVE PERIOD | 2019 |
|
RU2707875C1 |
| MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
| METHOD OF REHABILITATION AFTER HYPOXIA CAUSING BRAIN DYSFUNCTION IN LABORATORY ANIMAL MODELS | 2010 |
|
RU2437164C1 |
| METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
| STEROIDAL NITRONES FOR TREATMENT AND PREVENTION OF CEREBRAL STROKE OR ISCHEMIA, ALZHEIMER'S AND PARKINSON'S DISEASE AND AMYOTROPHIC LATERAL SCLEROSIS | 2014 |
|
RU2668514C2 |
| METHOD OF TREATING NEUROLOGICAL DISORDERS | 2008 |
|
RU2492137C2 |
